We are live on ! Find out more
ASA

Armstrong Shaw Associates Portfolio holdings

AUM $95.2M
1-Year Est. Return 23.67%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$421M
AUM Growth
+$18.1M
Cap. Flow
-$13.2M
Cap. Flow %
-3.13%
Top 10 Hldgs %
40.15%
Holding
50
New
Increased
4
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$7.97M
2
CVX icon
Chevron
CVX
+$7.9M
3
HON icon
Honeywell
HON
+$2.85M
4
APD icon
Air Products & Chemicals
APD
+$1.57M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.1M
2
F icon
Ford
F
+$7.02M
3
UNH icon
UnitedHealth
UNH
+$865K
4
DAL icon
Delta Air Lines
DAL
+$776K
5
CMCSA icon
Comcast
CMCSA
+$774K

Sector Composition

Rank Sector Weight
1 Financials 27.01%
2 Healthcare 18.12%
3 Technology 14.03%
4 Industrials 11.25%
5 Energy 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
1
Honeywell
HON
$77B
$19.1M 4.54%
182,316
+28,021
+18% +$2.85M
SYF icon
2
Synchrony
SYF
$23.7B
$18.1M 4.31%
499,546
-20,349
-4% -$650K
CMCSA icon
3
Comcast
CMCSA
$79.7B
$17.9M 4.26%
518,760
-23,172
-4% -$774K
DD icon
4
DuPont de Nemours
DD
$18.6B
$17.5M 4.16%
120,740
+57,239
+90% +$7.97M
AAPL icon
5
Apple
AAPL
$4.89T
$17.1M 4.06%
589,760
-19,940
-3% -$565K
MSFT icon
6
Microsoft
MSFT
$2.84T
$16.7M 3.97%
268,340
-10,280
-4% -$618K
ELV icon
7
Elevance Health
ELV
$81.9B
$16.6M 3.96%
115,706
-5,189
-4% -$695K
DAL icon
8
Delta Air Lines
DAL
$55.9B
$16M 3.8%
324,660
-17,011
-5% -$776K
CVX icon
9
Chevron
CVX
$388B
$15M 3.56%
127,133
+72,573
+133% +$7.9M
APD icon
10
Air Products & Chemicals
APD
$66.3B
$14.9M 3.55%
103,835
+11,251
+12% +$1.57M
COF icon
11
Capital One
COF
$124B
$14.9M 3.54%
170,673
-7,075
-4% -$570K
ICE icon
12
Intercontinental Exchange
ICE
$82.4B
$14.8M 3.52%
262,120
-10,585
-4% -$586K
UNH icon
13
UnitedHealth
UNH
$382B
$14.3M 3.41%
89,530
-5,791
-6% -$865K
HAL icon
14
Halliburton
HAL
$27.9B
$14.2M 3.38%
262,663
-13,049
-5% -$651K
NXPI icon
15
NXP Semiconductors
NXPI
$68B
$13.7M 3.26%
140,074
-5,094
-4% -$506K
CB icon
16
Chubb
CB
$140B
$13.5M 3.22%
102,528
-4,486
-4% -$572K
GOOG icon
17
Alphabet (Google) Class C
GOOG
$3.9T
$13.3M 3.16%
344,140
-15,020
-4% -$585K
WFC icon
18
Wells Fargo
WFC
$261B
$13.2M 3.15%
240,202
-9,770
-4% -$491K
CVS icon
19
CVS Health
CVS
$137B
$12.3M 2.93%
155,887
-5,654
-4% -$457K
GS icon
20
Goldman Sachs
GS
$313B
$12.1M 2.89%
50,704
-2,306
-4% -$468K
GE icon
21
GE Aerospace
GE
$367B
$12M 2.85%
79,226
-3,038
-4% -$441K
ABBV icon
22
AbbVie
ABBV
$458B
$12M 2.85%
191,183
-10,269
-5% -$627K
C icon
23
Citigroup
C
$222B
$11.4M 2.71%
191,801
-7,486
-4% -$404K
TMO icon
24
Thermo Fisher Scientific
TMO
$211B
$10.9M 2.58%
77,017
-2,954
-4% -$436K
AGN
25
DELISTED
Allergan plc
AGN
$9.9M 2.35%
47,148
-2,938
-6% -$609K

Similar funds

Armstrong Shaw Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Armstrong Shaw Associates held 50 positions worth $421M, up 4.5% from $402M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armstrong Shaw Associates withdrew a net $13.2M in Q4 2016, closing 6 positions and reducing 29 holdings. Its most notable exit was Amgen, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Armstrong Shaw Associates added an estimated $7.97M to DuPont de Nemours.

  • Armstrong Shaw Associates added most to DuPont de Nemours in Q4 2016, an estimated $7.97M increase.
  • Armstrong Shaw Associates's biggest Q4 2016 reduction was UnitedHealth, cutting an estimated $865K.
  • Armstrong Shaw Associates fully exited Amgen in Q4 2016, selling an estimated $11.1M.
  • Armstrong Shaw Associates's ten largest holdings make up 40% of its $421M portfolio in Q4 2016.
  • Armstrong Shaw Associates opened 0 new positions and closed 6 in Q4 2016.
  • Armstrong Shaw Associates's portfolio value rose 4.5% quarter-over-quarter to $421M.

Based on Armstrong Shaw Associates's 13F filing for Q4 2016, filed 20 Jan 2017.